Anzeige
Mehr »
Login
Dienstag, 03.12.2024 Börsentäglich über 12.000 News von 680 internationalen Medien
Eilmeldung: Goldshores aggressiver Winter-Explorationsplan nimmt Gestalt an
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DWCH | ISIN: GB00BMC3RJ87 | Ticker-Symbol: RYH0
Frankfurt
03.12.24
15:29 Uhr
0,298 Euro
0,000
0,00 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
SAREUM HOLDINGS PLC Chart 1 Jahr
5-Tage-Chart
SAREUM HOLDINGS PLC 5-Tage-Chart

Aktuelle News zur SAREUM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MiSareum sets date for annual general meeting1
MiSareum Holdings PLC - Notice of AGM, Annual Report and Accounts2
12.11.Sareum Holdings - SDC-1801 prepping to enter Phase II269Sareum Holdings' FY24 results summarised an active period for lead asset SDC-1801, a dual TYK2/JAK1 inhibitor, which successfully completed Phase I trials in Australia and is now undergoing preparatory...
► Artikel lesen
29.10.Sareum annual loss widens as remains focused on autoimmune diseases1
29.10.Sareum Holdings PLC - Final Results for the Year Ended 30 June 2024-
SAREUM Aktie jetzt für 0€ handeln
23.10.Sareum Holdings PLC - Notice of Final Results and Investor Presentation-
21.10.IN BRIEF: Sareum raises further GBP1.0 million via subscription3
21.10.Sareum Holdings PLC - Further Subscription to raise £1,000,000-
11.10.Sareum Holdings - New funding extends runway to Phase II298Sareum Holdings has announced the completion of a £2.4m private placement and receipt of another A$1.9m (c £1m) in R&D tax credits from Australian authorities, related to the Phase I clinical trial...
► Artikel lesen
11.10.Sareum Holdings completes GBP2.4 million fundraise to boost lead asset2
11.10.Sareum Holdings PLC - Subscription to raise £2,364,0002
16.09.Sareum shares rise on China patent allowance1
16.09.Sareum receives patent allowance for crystalline SDC-1801 in China1
16.09.Sareum Holdings PLC - Patent Allowance in China-
02.09.Sareum Holdings PLC - US patent allowance-
10.07.Sareum Co-Founder & CEO Tim Mitchell steps back after twenty years1
10.07.Sareum Holdings PLC - Management Changes-
02.07.Sareum Holdings - SDC-1801 records positive Phase Ia data286Sareum Holdings has announced positive top-line data from the Phase Ia clinical trial for SDC-1801, its lead asset, a novel TYK2/JAK1 inhibitor targeting autoimmune conditions. The results, which include...
► Artikel lesen
01.07.Sareum announces positive results from kinase inhibitor trial1
01.07.Sareum Holdings PLC - Positive Data from SDC-1801 Phase 1 Clinical Trial-
Seite:  Weiter >>
23 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1